Molecular profiling of neuroendocrine tumors (NETs): The Fox Chase Cancer Center (FCCC) experience.

被引：0
|
作者：
Vijayvergia, Namrata
Boland, Patrick McKay
Cohen, Steven J.
Gustafson, Karen S.
Cooper, Harry S.
Astsaturov, Igor A.
Engstrom, Paul F.
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
245
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Molecular Profiling Defines Subsets of Neuroendocrine Tumors (NETs) With Aggressive Disease: A Fox Chase Cancer Center (FCCC) Study
    Vijayvergia, Namrata
    Cohen, Steven J.
    Boland, Patrick M.
    Gustafson, Karen. S.
    Sherrif, Fathima
    Cooper, Harry
    Astaturov, Igor
    Engstrom, Paul F.
    [J]. PANCREAS, 2016, 45 (03) : 469 - 470
  • [2] Molecular Profiling of Advanced Stage Neuro Endocrine Tumors (NETs): The Fox Chase Cancer Center (FCCC) Experience
    Vijayvergia, Namrata
    Boland, Patrick M.
    Gustafson, Karen S.
    Sheriff, Fathima
    Cooper, Harry
    Cohen, Steven J.
    Astaturov, Igor
    Engstrom, Paul F.
    [J]. PANCREAS, 2015, 44 (02) : 349 - 350
  • [3] Influence of surgical interventions on survival in patients with stage IIIb non-small cell lung cancer (NSCLC): The Fox Chase Cancer Center (FCCC) experience.
    Scott, W. J.
    Aggarwal, C.
    Lebenthal, A.
    Egleston, B.
    Borghaei, H.
    Mehra, R.
    Somaiah, N.
    Turaka, A.
    Simon, G. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
    Vijayvergia, Namrata
    Boland, Patrick M.
    Handorf, Elizabeth
    Gustafson, Karen S.
    Gong, Yulan
    Cooper, Harry S.
    Sheriff, Fathima
    Astsaturov, Igor
    Cohen, Steven J.
    Engstrom, Paul F.
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (05) : 564 - 570
  • [5] Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
    Namrata Vijayvergia
    Patrick M Boland
    Elizabeth Handorf
    Karen S Gustafson
    Yulan Gong
    Harry S Cooper
    Fathima Sheriff
    Igor Astsaturov
    Steven J Cohen
    Paul F Engstrom
    [J]. British Journal of Cancer, 2016, 115 : 564 - 570
  • [6] Neuroendocrine tumors (NETs) - experience of a single Center
    Sincu, Mihaela Cornelia
    Cocuz, Iuliu Gabriel
    Tinca, Andreea Catalina
    Niculescu, Raluca
    Sabau, Adrian-Horatiu
    Chiorean, Diana Maria
    Morariu, Silviu Horia
    Cotoi, Ovidiu Simion
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2021, 62 (02): : 457 - 463
  • [7] Clinicopathologic features of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): A single-center experience.
    Telli, Tugba Akin
    Esin, Ece
    Yalcin, Suayib
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Clinicopathologic considerations of neuroendocrine tumors (NETs) in Greece: A registry experience.
    Koumarianou, Anna
    Nikou, George
    Dimitroulopoulos, Dimitrios
    Angelopoulos, Theodoros
    Papamichelakis, Michalis
    Mandanas, Stylianos
    Chrisoulidou, Alexandra
    Vlachou, Erasmia
    Alexandrakis, Georgios
    Papakostas, Pavlos
    Vaslamatzis, Michael
    Kaldrymidis, Philippos
    Malachias, Apostolos
    Alevizopoulos, Nektarios
    Katsaounis, Panagiotis
    Markussis, Vyron
    Pazaitou, Kalliopi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Population characteristics and prognostic factors in metastatic non-small cell lung cancer (NSCLC): The Fox Chase Cancer Center (FCCC) experience
    Paralkar, V.
    Li, T.
    Langer, C. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Fox Chase Cancer Center
    Robert C. Young
    [J]. Molecular Medicine, 1997, 3 : 491 - 495
12345